7th Annual CAR-TCR Summit Europe

Celebrating the Progress of Advanced Therapies and Building the Future Through Translations

Feb 27 - Feb 29, 2024

London, UK

Booth #2

Come visit us at booth #2 and discover MaxCyte's cGMP-compliant non-viral cell engineering platform and how it enables the acceleration of therapeutic development from concept to clinic.

While at the meeting, attend our feature presentation:


Featured Event

Next-generation CAR-based immunotherapies

Date: February 28, 2024
Time: 12:00 - 12:30 PM
Presenter: Sabrina Prommersberger, Postdoc, T-CURX


Significant efforts have been invested in the development of advanced genetic engineering methods for immune effector cells targeting cancer cells. In this talk, optimized virus-free gene editing strategies for CAR T cells, refinement of clinical translation and the impact on their application will be presented. Insights into future directions to accelerate and amplify production to deliver CAR products with curative potential will be explored.